Literature DB >> 20058265

Agonist-selective signaling of G protein-coupled receptor: mechanisms and implications.

Hui Zheng1, Horace H Loh, Ping-Yee Law.   

Abstract

Agonist-selective signaling or ligand-biased signaling of G protein-coupled receptor (GPCR) has become the focus of an increasing number of laboratories. The principle of this concept is that agonist possesses different abilities to activate different signaling pathways. Current review summarizes the observations of agonist-selective signaling of various GPCRs, indicating the significance of agonist-selective signaling in biological processes. In addition, current review also provides an overview on how agonist-selective signaling is initiated. Especially, the relationship between GPCR-G protein interaction and GPCR-beta-arrestin interaction is discussed in depth. (c) 2010 IUBMB IUBMB Life.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20058265      PMCID: PMC2809802          DOI: 10.1002/iub.293

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  80 in total

1.  Direct and differential interaction of beta-arrestins with the intracellular domains of different opioid receptors.

Authors:  B Cen; Y Xiong; L Ma; G Pei
Journal:  Mol Pharmacol       Date:  2001-04       Impact factor: 4.436

Review 2.  Molecular mechanisms and regulation of opioid receptor signaling.

Authors:  P Y Law; Y H Wong; H H Loh
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

3.  Crystal structure of rhodopsin: A G protein-coupled receptor.

Authors:  K Palczewski; T Kumasaka; T Hori; C A Behnke; H Motoshima; B A Fox; I Le Trong; D C Teller; T Okada; R E Stenkamp; M Yamamoto; M Miyano
Journal:  Science       Date:  2000-08-04       Impact factor: 47.728

4.  beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation.

Authors:  Akira Tohgo; Kristen L Pierce; Eric W Choy; Robert J Lefkowitz; Louis M Luttrell
Journal:  J Biol Chem       Date:  2002-01-02       Impact factor: 5.157

Review 5.  Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins.

Authors:  Audrey Claing; Stéphane A Laporte; Marc G Caron; Robert J Lefkowitz
Journal:  Prog Neurobiol       Date:  2002-02       Impact factor: 11.685

6.  Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane Translocation.

Authors:  M Han; V V Gurevich; S A Vishnivetskiy; P B Sigler; C Schubert
Journal:  Structure       Date:  2001-09       Impact factor: 5.006

Review 7.  Classical and new roles of beta-arrestins in the regulation of G-protein-coupled receptors.

Authors:  K L Pierce; R J Lefkowitz
Journal:  Nat Rev Neurosci       Date:  2001-10       Impact factor: 34.870

Review 8.  G protein pathways.

Authors:  Susana R Neves; Prahlad T Ram; Ravi Iyengar
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

9.  Palmitoylation occurs at cysteine 347 and cysteine 351 of the dopamine D(1) receptor.

Authors:  H Jin; Z Xie; S R George; B F O'Dowd
Journal:  Eur J Pharmacol       Date:  1999-12-15       Impact factor: 4.432

10.  Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase.

Authors:  David M Mottola; Jason D Kilts; Mechelle M Lewis; Hilary S Connery; Q David Walker; Sara R Jones; Raymond G Booth; Deborah K Hyslop; Monford Piercey; R Mark Wightman; Cindy P Lawler; David E Nichols; Richard B Mailman
Journal:  J Pharmacol Exp Ther       Date:  2002-06       Impact factor: 4.030

View more
  32 in total

1.  Yin Yang 1 phosphorylation contributes to the differential effects of mu-opioid receptor agonists on microRNA-190 expression.

Authors:  Hui Zheng; Ji Chu; Yan Zeng; Horace H Loh; Ping-Yee Law
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  G-protein βγ subunits in vasorelaxing and anti-endothelinergic effects of calcitonin gene-related peptide.

Authors:  M J P M T Meens; N J A Mattheij; P B van Loenen; L J A Spijkers; P Lemkens; J Nelissen; M G Compeer; A E Alewijnse; J G R De Mey
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 3.  Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches.

Authors:  Claire Gavériaux-Ruff; Brigitte Lina Kieffer
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

4.  Wheel running reduces high-fat diet intake, preference and mu-opioid agonist stimulated intake.

Authors:  Nu-Chu Liang; Nicholas T Bello; Timothy H Moran
Journal:  Behav Brain Res       Date:  2015-02-07       Impact factor: 3.332

5.  Endocytic profiles of δ-opioid receptor ligands determine the duration of rapid but not sustained cAMP responses.

Authors:  Hanieh Bagheri Tudashki; Derek N Robertson; Peter W Schiller; Graciela Pineyro
Journal:  Mol Pharmacol       Date:  2013-10-30       Impact factor: 4.436

6.  In Silico Modeling of Novel Drug Ligands for Treatment of Concussion Associated Tauopathy.

Authors:  Wei Zhao; Lap Ho; Jun Wang; Weina Bi; Shrishailam Yemul; Libby Ward; Daniel Freire; Paolo Mazzola; Justin Brathwaite; Mihaly Mezei; Roberto Sanchez; Gregory A Elder; Giulio Maria Pasinetti
Journal:  J Cell Biochem       Date:  2016-07-12       Impact factor: 4.429

Review 7.  Biophysical characterization of G-protein coupled receptor-peptide ligand binding.

Authors:  David N Langelaan; Pascaline Ngweniform; Jan K Rainey
Journal:  Biochem Cell Biol       Date:  2011-04       Impact factor: 3.626

8.  Cannabinoids inhibit migration of microglial-like cells to the HIV protein Tat.

Authors:  Daniel Fraga; Erinn S Raborn; Gabriela A Ferreira; Guy A Cabral
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-07       Impact factor: 4.147

9.  Lanthanide labeling of a potent protease activated receptor-2 agonist for time-resolved fluorescence analysis.

Authors:  Justin Hoffman; Andrea N Flynn; Dipti V Tillu; Zhenyu Zhang; Renata Patek; Theodore J Price; Josef Vagner; Scott Boitano
Journal:  Bioconjug Chem       Date:  2012-10-08       Impact factor: 4.774

10.  Cholesterol level influences opioid signaling in cell models and analgesia in mice and humans.

Authors:  Hui Zheng; Haibo Zou; Xiaopeng Liu; Ji Chu; Yali Zhou; Horace H Loh; Ping-Yee Law
Journal:  J Lipid Res       Date:  2012-02-29       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.